NWMP
GSK icon

Noble Wealth Management PBC’s GSK GSK Stock Holding History

Noble Wealth Management PBC’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$839 Buy
+16
New +$846 ﹤0.01% 734
2025
Q1 		$3.25K Hold
84
– – ﹤0.01% 463
2024
Q4 		$2.84K Buy
+84
New +$3.02K ﹤0.01% 429

Other funds holding GSK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
TH
Transmarket Holdings Chicago, Illinois $136M AUM

Noble Wealth Management PBC's GSK Position: Q2 2026 in Review

Noble Wealth Management PBC opened a new position in GSK (GSK) in Q2 2026: 16 shares worth $839. The stake represents ﹤0.01% of the portfolio and ranks #734 among its holdings. This is a return to the name: Noble Wealth Management PBC previously reported a position in GSK as recently as Q1 2025.

Noble Wealth Management PBC first reported a position in GSK in Q4 2024 and has held it in 3 quarters since. The position peaked at $3.25K in Q1 2025. 296 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Noble Wealth Management PBC held 16 shares of GSK worth $839 as of Q2 2026.
  • GSK was a new Noble Wealth Management PBC position in Q2 2026.
  • GSK made up ﹤0.01% of Noble Wealth Management PBC's portfolio in Q2 2026, its #734 holding.
  • Noble Wealth Management PBC first reported a position in GSK in Q4 2024 and has held it in 3 quarters since.
  • Noble Wealth Management PBC's GSK position peaked at $3.25K in Q1 2025.
  • 296 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Noble Wealth Management PBC's 13F filing for Q2 2026, filed 1 Jul 2026.